Atlas FDA

NEVRO SENZA SPINAL CORD STIMULATION (SCS) SYSTEM

FDA premarket approval P130022/S012 · decided 2017-03-01

Approval details

PMA number
P130022
Supplement
S012
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
NEVRO SENZA SPINAL CORD STIMULATION (SCS) SYSTEM
Generic name
Stimulator, spinal-cord, totally implanted for pain relief
Applicant
Nevro Corporation
Date received
2017-02-01
Decision date
2017-03-01
Days to decision
28 days
Decision code
OK30
Product code
LGW
Advisory committee
Neurology
Expedited review
No
Location
Redwood City, CA
Statement
Implement manufacturing process changes to allow for the use of virtual machine software (VMware) to provide an isolated and safe environment fromwhich to run the FDA approved PG2000 Clinician Programmer software v1.7.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.